Personalised management of community-acquired pneumonia and the role of Clinical Decision Support Software
Abstract
Community-acquired pneumonia (CAP) is one of the most common causes of hospital admission and is associated with significant morbidity and mortality. National and international guidelines are available to guide the management of CAP, including antibiotic prescribing. However, these guidelines are often not adhered to and there is significant overprescribing of broad-spectrum antibiotics, contributing to the growing pandemic of antimicrobial resistance. Clinical Decision Support Software (CDSS) are electronic tools that use individual patient data to generate patient specific assessments or recommendations, that can then be acted on by the patient or clinical decision maker. This article reviews the evidence surrounding the initial management of CAP in hospital and considers the potential of CDSS to support CAP management.
Fields of Study & Subjects
Pneumonia and Respiratory Infections
Nosocomial Infections in ICU
Antibiotic Use and Resistance
Publication details
- Journal / source
- BMJ Open Respiratory Research
- Publisher
- BMJ
- Volume
- 13
- Issue
- 1
- Pages
- e003096–e003096
- Publication date
- 1 April 2026
- Language
- EN